ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,629.00
0.55%
S&P ASX All Technology
3,016.30
1.48%
Brent Oil
82.765
0.00%
US Dollar vs AUD
1.514
-0.05%
Bitcoin
63,632.22
1.18%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Bone Biologics Corporation (BBLG)

  7. Bone Biologics Corporation (BBLG) News

BBLG Bone Biologics Corporation

1.723
-0.1243 (-6.73%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Bone Biologics Corporation BBLG NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.1243 -6.73% 1.723 10:00:00
Open Price Low Price High Price Close Price Previous Close
1.90 1.80 1.9418 1.85 1.8473
more quote information »

Recent News

Date Time Source Heading
07/3/202408:15BWBone Biologics Announces Closing of $2.0 Million Public..
05/3/202416:15EDGAR2Form EFFECT - Notice of Effectiveness
05/3/202409:21EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
05/3/202401:15BWBone Biologics Announces Pricing of $2.0 Million Public..
02/3/202400:05EDGAR2Form 8-K - Current report
02/3/202400:00BWBone Biologics Reports Progress With NB1 Clinical Program
27/2/202408:50EDGAR2Form S-1/A - General form for registration of securities..
24/2/202409:09EDGAR2Form S-1/A - General form for registration of securities..
22/2/202409:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/2/202410:41EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202402:55EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202412:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202409:09EDGAR2Form S-1 - General form for registration of securities under..
20/1/202409:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202409:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202409:21EDGAR2Form S-3/A - Registration statement under Securities Act of..
13/1/202409:15EDGAR2Form 8-K - Current report
12/1/202400:15EDGAR2Form 8-K - Current report
12/1/202400:00BWBone Biologics Appoints Healthcare Finance Veteran Robert E...
11/1/202409:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202400:15EDGAR2Form 8-K - Current report
11/1/202400:00BWBone Biologics Regains Compliance with Nasdaq Continued..
06/1/202409:15EDGAR2Form S-3 - Registration statement under Securities Act of..
03/1/202409:15EDGAR2Form 8-K - Current report
03/1/202407:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
21/12/202309:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19/12/202300:05EDGAR2Form 8-K - Current report
19/12/202300:00BWBone Biologics Announces 1-for-8 Reverse Stock Split
14/12/202301:15EDGAR2Form 8-K - Current report
27/11/202322:10EDGAR2Form SC 13G - Statement of acquisition of beneficial..
21/11/202304:38BWBone Biologics Announces Closing of Registered Direct..
20/11/202323:46EDGAR2Form 8-K - Current report
20/11/202323:44EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/11/202323:00EDGAR2Form DEF 14A - Other definitive proxy statements
20/11/202322:50EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
17/11/202308:43BWBone Biologics Announces Registered Direct Offering Priced..
15/11/202308:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202308:51EDGAR2Form PRE 14A - Other preliminary proxy statements
24/10/202321:06EDGAR2Form 8-K - Current report
30/9/202307:19EDGAR2Form 8-K - Current report
26/9/202322:00BWBone Biologics Provides Scientific Update on NB1 Bone Graft..
21/9/202304:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202304:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202304:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/9/202306:48EDGAR2Form S-8 - Securities to be offered to employees in employee..
15/9/202301:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202306:01EDGAR2Form 8-K - Current report
13/9/202301:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202300:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202307:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

NASDAQ
BBLG
Bone Biologics
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved